Dr. Keenan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Certifications & Licensure
MA State Medical License 2015 - 2022
Publications & Presentations
PubMed
- 54 citationsGermline variants associated with toxicity to immune checkpoint blockade.Stefan Groha, Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H Nassar
Nature Medicine. 2022-12-01 - 20 citationsPhase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer.Adrienne G Waks, Tanya E Keenan, Tianyu Li, Nabihah Tayob, Gerburg M Wulf
Journal for Immunotherapy of Cancer. 2022-10-01 - 6 citationsMultidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier, Zachary T Weber, Tejas R Jammihal
JCO Precision Oncology. 2022-07-01
Press Mentions
- Integrated Molecular Drivers Coordinate Biological and Clinical States in MelanomaNovember 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
